This fact sheet summarizes the technical efforts and objectives of PATH's non-replicating rotavirus vaccine (NRRV) project. It outlines the vaccine candidates under evaluation and primary partners, as well as the rationale for the NRRV approach.

Corporate author(s): PATH

Publication date: January 2013

Available materials


Exploring New, Non-replicating Rotavirus Vaccines

172 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Global

See also: Vaccines and immunization > Diarrheal disease

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA